Instrument Inactif

Autres langues StemCells Inc Nasdaq

Actions

US85857R2040

Recherche biotechnologique et médicale

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

23/06	Microbot Medical annonce que le premier réseau de santé en Pennsylvanie adopte le système robotisé endovasculaire Liberty	CI
16/06	Microbot Medical Inc. conclut un accord avec Lovell Government Services pour élargir l'accès aux soins des vétérans et des militaires américains	CI

Autres langues

07/07	Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
30/06	Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader
25/06	Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
25/06	Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
23/06	Microbot Medical Announces First Health System in Pennsylvania to Adopt the Liberty Endovascular Robotic System
23/06	Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
17/06	Microbot Medical Enters into an Agreement to Expand Access for America's Veteran and Military Patient Populations
16/06	Microbot Medical Inc. Enters Into Agreement With Lovell Government Services To Expand Access For America?s Veteran And Military Patient Populations
16/06	Microbot Medical Enters Agreement Expanding Access to Federal Healthcare Systems
16/06	Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
09/06	Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
09/06	Microbot Medical Inc. Announces A Notable Health System as the First in Michigan to Adopt the Liberty Endovascular Robotic System
02/06	Microbot Medical Inc. Secures First North Carolina Healthcare System to Adopt the LIBERTY Endovascular Robotic System
02/06	Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
26/05	Microbot Medical Inc. Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY Endovascular Robotic System
26/05	Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
15/05	Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
14/05	Microbot Medical recorded revenue during its quarter ended March 31, benefiting from limited market release of Liberty System
14/05	Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
13/05	Microbot Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
05/05	Microbot Medical®'s Liberty® endovascular robotic system is now adopted by multiple accounts across key territories including two Access-PVI pivotal clinical trial sites
05/05	Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
05/05	Microbot Medical Inc Wins Accounts for Liberty Endovascular Robotic System Across Key Territories
01/05	Microbot Medical Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia
30/04	Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)